BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  New Medical Applications are Expected to Boost Cannabis Value

  According to the data provided by Energias Market Research, the global medical cannabis market is anticipated to increase in value from USD 8.28 Billion in 2017 to USD 28.07 Billion in 2024

  June 15, 2018

   · 

  12 min read
• Biotech Beach

  AMN Healthcare Recognized for Predictive Analytics that Help Healthcare Organizations Hire Quality Clinicians

  AMN’s candidate intelligence processes provide unparalleled opportunities for hospitals and other healthcare organizations to find the quality professionals they need for excellence in patient care.

  June 15, 2018

   · 

  2 min read
• Drug Development

  Kadmon Announces Updated Results of KD025 in cGVHD at EHA Congress

  Results from the study will be presented in an oral session on Saturday, June 16th, 2018 at the 23rd Congress of the European Hematology Association (EHA) in Stockholm, Sweden.

  June 15, 2018

   · 

  6 min read
• Global Oligonucleotide Therapeutics Market 2018-2022 | Increasing Incidence of Cancer to Boost Growth| Technavio

  The global oligonucleotide therapeutics market is expected to post a CAGR of close to 10% over the period 2018-2022

  June 15, 2018

   · 

  4 min read
• Genetown

  Ra Pharmaceuticals Presents Data on Oral, Small Molecule Complement Inhibitors and Phase 2 RA101495 SC Program in PNH at the 23rd Congress of the European Hematology Association

  Presentation of scientific data at the 23rd Congress of the European Hematology Association (EHA), June 14-17, 2018 in Stockholm, Sweden.

  June 15, 2018

   · 

  7 min read
• Drug Development

  Acceleron Announces Updated Results from Ongoing Phase 2 Trials of Luspatercept in Beta-Thalassemia at the 23rd Congress of the European Hematology Association

  Clinically meaningful increases in hemoglobin and reductions in red blood cell transfusion burden observed through 36 months

  June 15, 2018

   · 

  6 min read
• BioMidwest

  HCR ManorCare Honors 2018 First-Quarter National Champion of Caring

  Company has taken the recognition a step higher in launching a program that honors on a quarterly basis an HCR ManorCare Champion of Caring, a national champion across all service lines.

  June 15, 2018

   · 

  3 min read
• BioCapital

  Foundation Fighting Blindness Clinical Research Institute Hosted Workshop for ProgStar, the Largest Natural History Study for Stargardt Disease Ever Launched

  The primary goal of the landmark study, funded by the Foundation, is to provide companies and researchers with disease-progression data and potential clinical trial endpoints to drive therapy development

  June 15, 2018

   · 

  3 min read
• Drug Development

  MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress

  --Initiation of registration study for ME-401 in patients with relapsed or refractory follicular lymphoma expected before year-end--

  June 15, 2018

   · 

  5 min read
• Drug Development

  Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache

  Teva Pharmaceutical Industries Ltd. today announced a change in the clinical development program of fremanezumab in chronic cluster headache.

  June 15, 2018

   · 

  7 min read